BamSEC and AlphaSense Join Forces
Learn More

Capricor Therapeutics Inc.

NASDAQ: CAPR    
Share price (12/24/24): $14.01    
Market cap (12/24/24): $637 million
Search in Documents
Key Exhibits
External Links

Material Contracts Filter

EX-10.6
from 10-Q ~5 pages ​ Seventh Amendment to Facilities Lease ​
12/34/56
EX-10.1
from 10-Q 3 pages ​ *Portions of the Exhibit Have Been Excluded Because It Is Both Not Material and Is the Type of Information That the Registrant Treats as Private or Confidential. ​ Term Sheet for Distribution of Deramiocel (Cap-1002) in Europe ​
12/34/56
EX-10.3
from 8-K 2 pages Letter of Intent September 16, 2024 ​ Confidential ​ Capricor Therapeutics, Inc. ​ Dear Dr. Linda Marbán: ​
12/34/56
EX-10.2
from 8-K 19 pages Registration Rights Agreement
12/34/56
EX-10.1
from 8-K 23 pages Signature Page to Subscription Agreement
12/34/56
EX-10.1
from 8-K 21 pages Securities Purchase Agreement ​
12/34/56
EX-10.55
from 10-K 48 pages *Portions of the Exhibit Have Been Excluded Because It Is Both Not Material and Is the Type of Information That the Registrant Treats as Private or Confidential. Commercialization and Distribution Agreement
12/34/56
EX-10.55
from 10-K 42 pages *Portions of the Exhibit Have Been Excluded Because It Is Both Not Material and Is the Type of Information That the Registrant Treats as Private or Confidential. Commercialization and Distribution Agreement
12/34/56
EX-10.54
from 10-K 47 pages *Portions of the Exhibit Have Been Excluded Because It Is Both Not Material and Is the Type of Information That the Registrant Treats as Private or Confidential. Standard Industrial/Commercial Multi-Tenant Lease Net
12/34/56
EX-10.3
from 10-Q 9 pages ​ Capricor Therapeutics, Inc. ​ 2021 Equity Incentive Plan ​ Stock Option Agreement
12/34/56
EX-10.2
from 10-Q 10 pages ​ Capricor Therapeutics, Inc. ​ 2021 Equity Incentive Plan
12/34/56
EX-10.1
from 10-Q 36 pages ​ Exclusive License Agreement Johns Hopkins University and Capricor, Inc. Jhu Agreement Number A38423
12/34/56
EX-10.1
from 10-Q 6 pages *Portions of This Exhibit Have Been Excluded Because It Both (I) Is Not Material and (II) Would Be Competitively Harmful if Publicly Disclosed. Seventh Amendment to Exclusive License Agreement
12/34/56
EX-10.1
from 8-K 6 pages Holder of Common Stock Purchase Warrant Re: Inducement Offer to Exercise Common Stock Purchase Warrants Dear Holder
12/34/56
EX-10.3
from 10-Q 10 pages Employment Agreement
12/34/56
EX-10.2
from 10-Q 10 pages Employment Agreement
12/34/56
EX-10.1
from 10-Q 11 pages Restated and Amended Employment Agreement
12/34/56
EX-10.1
from 8-K 24 pages Capricor Therapeutics, Inc. Common Stock Sales Agreement
12/34/56
EX-10.2
from 10-Q 4 pages Fifth Amendment to Exclusive License Agreement
12/34/56
EX-10.1
from 10-Q 4 pages Fourth Amendment to Amended and Restated Exclusive License Agreement
12/34/56